Details for Patent: 6,759,398
✉ Email this page to a colleague
Summary for Patent: 6,759,398
| Title: | Anti-inflammatory androstane derivative |
| Abstract: | According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I),or a solvate thereof, together with a long-acting beta2-adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of inflammatory disorders of the respiratory tract over a period of 24 hours or more. |
| Inventor(s): | Keith Biggadike |
| Assignee: | GlaxoSmithKline Intellectual Property Development Ltd , SmithKline Beecham Corp |
| Application Number: | US10/066,836 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,759,398 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 6,759,398
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,759,398
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0019172 | Aug 05, 2000 |
International Family Members for US Patent 6,759,398
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1305329 | ⤷ Start Trial | 91429 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 1305329 | ⤷ Start Trial | CA 2008 00022 | Denmark | ⤷ Start Trial |
| European Patent Office | 1305329 | ⤷ Start Trial | 300343 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1305329 | ⤷ Start Trial | SPC011/2008 | Ireland | ⤷ Start Trial |
| European Patent Office | 1305329 | ⤷ Start Trial | 08C0014 | France | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
